Lorenzi, Matthew V.,Platero, Suso Jesus,Verona, Raluca,Karkera, Jayaprakash
申请号:
AU2016243917
公开号:
AU2016243917A1
申请日:
2016.04.01
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
Provided herein are combination therapies for the treatment of cancer. In particular, the disclosed methods are directed to treatment of cancer in a patient comprising administering an antibody that blocks the interaction between PD-1 and PD-L1 and an FGFR inhibitor, wherein the antibody that blocks the interaction between PD-1 and PD-L1 and the FGFR inhibitor are administered if one or more FGFR variants are present in a biological sample from the patient.